Mediclin AG
XHAM:MED

Watchlist Manager
Mediclin AG Logo
Mediclin AG
XHAM:MED
Watchlist
Price: 2.86 EUR -2.05% Market Closed
Market Cap: 204.8m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one MED stock under the Base Case scenario is 13.99 EUR. Compared to the current market price of 2.86 EUR, Mediclin AG is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MED Relative Value
Base Case
13.99 EUR
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
71
vs Industry
88
Median 3Y
0.2
Median 5Y
0.2
Industry
2.2
Forward
0.2
More Details
5.7
P/E
P/E
Price to Earnings
5.7
vs History
47
vs Industry
45
Median 3Y
6.5
Median 5Y
5.6
Industry
21.8
Forward
5.9
More Details
1.7
P/OCF
P/OCF
Price to OCF
1.7
vs History
69
vs Industry
55
Median 3Y
2.1
Median 5Y
2.1
Industry
13.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-3.1
Industry
19
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
79
vs Industry
73
Median 3Y
0.7
Median 5Y
0.8
Industry
2.1
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
66
vs Industry
79
Median 3Y
0.5
Median 5Y
0.6
Industry
2.3
Forward
0.5
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
66
vs Industry
85
Median 3Y
0.6
Median 5Y
0.7
Industry
4.8
More Details
3.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.7
vs History
80
vs Industry
51
Median 3Y
3.8
Median 5Y
4.7
Industry
11.4
Forward
4
More Details
6.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
6.7
vs History
80
vs Industry
22
Median 3Y
18.5
Median 5Y
19.6
Industry
15.5
Forward
8.3
More Details
5
EV/OCF
EV/OCF
Enterprise Value to OCF
5
vs History
52
vs Industry
50
Median 3Y
5
Median 5Y
5
Industry
13.3
More Details
11.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.2
vs History
28
vs Industry
36
Median 3Y
10
Median 5Y
9.4
Industry
17.1
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
52
vs Industry
76
Median 3Y
0.5
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

MED Competitors Multiples
Mediclin AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Mediclin AG
XHAM:MED
140.6m EUR 0.2 5.7 3.7 6.7
US
HCA Healthcare Inc
NYSE:HCA
82B USD 1.2 14.2 8.5 11.2
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 8.7 42.3 37.1 43.8
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
20.9B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
18B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
122.3B CNY 5.9 33.7 25.4 25.4
MY
IHH Healthcare Bhd
KLSE:IHH
60.5B MYR 2.5 22.8 12 17.1
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1T INR 15.9 102.9 61.9 74.8
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
69.8B BRL 1.4 18.1 7.3 8.9
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
999.7B INR 4.7 76.3 36.1 47.6
US
Tenet Healthcare Corp
NYSE:THC
11.6B USD 0.6 3.6 5.4 6.7

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.